๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
870 KB
Volume
39
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Effects of levodopa and COMT inhibitors
โœ Paolo Lamberti; Stefano Zoccolella; Giovanni Iliceto; Elio Armenise; Angela Frad ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 70 KB ๐Ÿ‘ 1 views

## Abstract Homocysteine (Hcy) is a risk factor for vascular diseases, cognitive impairment, and dementia. Elevated plasma concentrations of Hcy have been found recently in Parkinson's disease (PD) patients treated with levodopa, suggesting that levodopa is a cause of hyperhomocysteinemia (HHcy). T

Predictors of time to requiring dopamine
โœ Connie Marras; Michael P. McDermott; Ken Marek; Paula Rochon; Gary Naglie; Carol ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 101 KB ๐Ÿ‘ 1 views

## Abstract The rate of progression of Parkinson's disease (PD) is highly variable. Knowledge of factors associated with disease milestones and commonly used research outcome measures helps with patient counseling and guides the design and interpretation of clinical studies. The objective of the st

The impact of treatment of depression on
โœ Matthew Menza; Roseanne DeFronzo Dobkin; Humberto Marin; Margery H. Mark; Michae ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 318 KB ๐Ÿ‘ 1 views

## Abstract Parkinson's disease (PD) is a common neurodegenerative disease affecting up to one million individuals in the United States. Depression is found in 40 to 50% of these patients and is associated with a variety of poor outcomes for both patients and their families. Despite this, there are